Piyush Goyal discusses investment opportunities with Bayer, Fresenius
Benchmarks Nifty22,500.75-186.91FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return8.69 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return18.25 % Invest NowEnter search…
Piyush Goyal held meetings with Bayer and Fresenius executives to discuss investment opportunities in India's healthcare sector. During these discussions, Goyal explored Bayer's expansion plans and potential collaborations in healthcare. He also examined how Fresenius can leverage India's skilled workforce for the healthcare market. Additionally, Goyal engaged with Knauf Group regarding sustainable construction materials and manufacturing operations in India. These meetings highlight India's growing role in global healthcare and manufacturing.
Berlin, Commerce and Industry Minister Piyush Goyal has held meetings with senior executives of pharmaceutical major Bayer and healthcare group Fresenius to discuss investment opportunities in India.During his meeting with Stefan Oelrich, President of the Pharmaceuticals Division at Bayer, Goyal said he discussed Bayer's expansion plans in India and opportunities to deepen its engagement with the country's robust healthcare ecosystem through greater investment, innovation and collaboration.
Also read: Goyal reminds developed countries of $100 bln climate finance pledge, says 'haven't seen nickel or dime of that'
"Had a fruitful meeting with Mr. Michael Sen, CEO of Fresenius Group. Discussed opportunities to deepen collaboration in healthcare, leveraging India's rapidly expanding healthcare sector, growing demand for quality and affordable medical solutions, and strong manufacturing capabilities," Goyal said in a social media post.
He explored how the group can harness India's skilled talent to serve both domestic and global markets.
Live Events
During his meeting with Murat Akyildiz, Global General Partner at Knauf Group, Goyal discussed the company's expanding manufacturing operations in India and avenues to deepen collaboration in sustainable construction materials and infrastructure development.
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onIndia healthcare ecosystemPiyush Goyal investment opportunitiesBayer pharmaceutical investment IndiaFresenius healthcare collaborationsustainable construction materials IndiaBayerFreseniusKnauf Groupfresenius grouppiyush goyal
(You can now subscribe to our Economic Times WhatsApp channel)
Read More News onIndia healthcare ecosystemPiyush Goyal investment opportunitiesBayer pharmaceutical investment IndiaFresenius healthcare collaborationsustainable construction materials IndiaBayerFreseniusKnauf Groupfresenius grouppiyush goyal Prime ExclusivesInvestment IdeasStock Report PlusePaperWealth Edition
KYB and KYC: Business behind the wealth creator called “Divi’s Lab” – Part 1
The global business of promising more
One company, 2 words. Bond yield and CDS: Will they decide the fate of global markets?
Business of Odd Things: Inside an industry that farms fish that nobody is meant to eat
War's second-order effects are becoming visible in critical sectors
US mid-term elections – Part 2: What does it mean for Trump to lose control of Congress?
- 1
- 2
- 3
Stories you might be interested in
Figures reflect the source report and its stated period. This article is for information and is not investment advice.
